Detalhe da pesquisa
1.
Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study).
Ophthalmology
; 127(9): 1201-1210, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32402554
2.
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
JAMA
; 324(23): 2383-2395, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33320223
3.
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.
JAMA
; 321(19): 1880-1894, 2019 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31037289
4.
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
N Engl J Med
; 372(13): 1193-203, 2015 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25692915
5.
EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG Substudy.
Retina
; 38(2): 364-378, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28198785
6.
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
JAMA
; 314(20): 2137-2146, 2015 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26565927
7.
Changes in activity impairment and work productivity after treatment for vitreous hemorrhage due to proliferative diabetic retinopathy: Secondary outcomes from a randomized controlled trial (DRCR Retina Network Protocol AB).
PLoS One
; 18(11): e0293543, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972038
8.
HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration.
Ophthalmology
; 119(6): 1175-83, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22306121
9.
Contact focusing multimodal microprobes for ultraprecise laser tissue surgery.
Opt Express
; 19(4): 3440-8, 2011 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21369166
10.
Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Ophthalmol
; 139(7): 725-733, 2021 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33956075
11.
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial.
JAMA Ophthalmol
; 139(7): 701-712, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33784735
12.
Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.
Ophthalmol Retina
; 4(1): 3-12, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31395505
13.
Phase 1 Study of OPT-302 Inhibition of Vascular Endothelial Growth Factors C and D for Neovascular Age-Related Macular Degeneration.
Ophthalmol Retina
; 4(3): 250-263, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31924544
14.
"Pacman" invasion of the retina: Two cases of ophthalmomyiasis interna posterior.
Am J Ophthalmol Case Rep
; 15: 100491, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31249904
15.
Night vision symptoms and progression of age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.
Ophthalmology
; 115(11): 1876-82, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18672295
16.
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results.
Am J Ophthalmol
; 145(5): 862-74, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18321465
17.
Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy.
Am J Ophthalmol
; 145(5): 894-901, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18294608
18.
Usability of the Ranibizumab 0.5 mg Prefilled Syringe: Human Factors Studies to Evaluate Critical Task Completion by Healthcare Professionals.
PDA J Pharm Sci Technol
; 72(4): 411-419, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29853609
19.
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
JAMA Ophthalmol
; 136(10): 1138-1148, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30043039
20.
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
Ophthalmology
; 114(2): 246-52, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17270674